美国 · SEC FORM 4
Maze Therapeutics, Inc.
MAZE · Nasdaq · CIK 0001842295 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
72 同一窗口内观察到的 Form 4 交易行
53 sales · 19 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 6,565,330
- 上期报告
- 5,678,289
- 日均成交量
- 1,080,934
- 回补天数
- 6.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
143 transaction lines in the latest 365-day window; 151 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Coloma Jason V | 卖出 (S) | Common Stock | 34,501 | USD 27.02 | USD 932,260 | SEC 申报 ↗ |
| 2026-10-01 | Bernstein Harold | 卖出 (S) | Common Stock | 16,141 | USD 26.93 | USD 434,743 | SEC 申报 ↗ |
| 2026-10-01 | Bernstein Harold | 期权行权／转换 (M) | Common Stock | 16,141 | USD 10.42 | USD 168,189 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Coloma Jason V | 卖出 (S) | Common Stock | 34,501 | USD 27.02 | USD 932,260 | SEC 申报 ↗ |
| 2026-10-01 | Bernstein Harold | 卖出 (S) | Common Stock | 16,141 | USD 26.93 | USD 434,743 | SEC 申报 ↗ |
| 2026-10-01 | Bernstein Harold | 期权行权／转换 (M) | Common Stock | 16,141 | USD 10.42 | USD 168,189 | SEC 申报 ↗ |
| 2026-09-29 | Dandekar Atul | 卖出 (S) | Common Stock | 7,500 | USD 27.06 | USD 202,921 | SEC 申报 ↗ |
| 2026-09-29 | Dandekar Atul | 期权行权／转换 (M) | Common Stock | 7,500 | USD 10.42 | USD 78,150 | SEC 申报 ↗ |
| 2026-09-04 | Bernstein Harold | 卖出 (S) | Common Stock | 9,705 | USD 26.22 | USD 254,465 | SEC 申报 ↗ |
| 2026-09-03 | Dandekar Atul | 卖出 (S) | Common Stock | 3,243 | USD 26.01 | USD 84,343 | SEC 申报 ↗ |
| 2026-09-03 | Courtney Phillips | 卖出 (S) | Common Stock | 2,012 | USD 26.01 | USD 52,327 | SEC 申报 ↗ |
| 2026-09-03 | Coloma Jason V | 卖出 (S) | Common Stock | 11,411 | USD 26.01 | USD 296,769 | SEC 申报 ↗ |
| 2026-09-03 | Bernstein Harold | 卖出 (S) | Common Stock | 5,189 | USD 26.01 | USD 134,952 | SEC 申报 ↗ |
| 2026-09-02 | Dandekar Atul | 卖出 (S) | Common Stock | 3,191 | USD 26.47 | USD 84,468 | SEC 申报 ↗ |
| 2026-09-02 | Courtney Phillips | 卖出 (S) | Common Stock | 1,981 | USD 26.47 | USD 52,439 | SEC 申报 ↗ |
| 2026-09-02 | Coloma Jason V | 卖出 (S) | Common Stock | 11,227 | USD 26.47 | USD 297,186 | SEC 申报 ↗ |
| 2026-09-02 | Bernstein Harold | 卖出 (S) | Common Stock | 5,106 | USD 26.47 | USD 135,159 | SEC 申报 ↗ |
| 2026-09-01 | Dandekar Atul | 期权行权／转换 (M) | Common Stock | 12,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | Courtney Phillips | 期权行权／转换 (M) | Common Stock | 11,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | Coloma Jason V | 卖出 (S) | Common Stock | 34,501 | USD 26.29 | USD 907,083 | SEC 申报 ↗ |
| 2026-09-01 | Coloma Jason V | 期权行权／转换 (M) | Common Stock | 50,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-01 | Bernstein Harold | 卖出 (S) | Common Stock | 16,141 | USD 26.36 | USD 425,477 | SEC 申报 ↗ |
| 2026-09-01 | Bernstein Harold | 期权行权／转换 (M) | Common Stock | 36,141 | USD 4.65 | USD 168,189 | SEC 申报 ↗ |
| 2026-08-28 | Dandekar Atul | 卖出 (S) | Common Stock | 7,500 | USD 27.58 | USD 206,850 | SEC 申报 ↗ |
| 2026-08-28 | Dandekar Atul | 期权行权／转换 (M) | Common Stock | 7,500 | USD 10.42 | USD 78,150 | SEC 申报 ↗ |
| 2026-08-13 | Bernstein Harold | 卖出 (S) | Common Stock | 16,142 | USD 27.61 | USD 445,681 | SEC 申报 ↗ |
| 2026-08-13 | Bernstein Harold | 期权行权／转换 (M) | Common Stock | 16,142 | USD 10.42 | USD 168,200 | SEC 申报 ↗ |
| 2026-08-03 | Coloma Jason V | 卖出 (S) | Common Stock | 34,501 | USD 26.73 | USD 922,190 | SEC 申报 ↗ |
| 2026-07-29 | Dandekar Atul | 卖出 (S) | Common Stock | 7,500 | USD 27.34 | USD 205,057 | SEC 申报 ↗ |
| 2026-07-29 | Dandekar Atul | 期权行权／转换 (M) | Common Stock | 7,500 | USD 10.42 | USD 78,150 | SEC 申报 ↗ |
| 2026-07-01 | Coloma Jason V | 卖出 (S) | Common Stock | 34,501 | USD 29.97 | USD 1,034,165 | SEC 申报 ↗ |
| 2026-07-01 | Bernstein Harold | 卖出 (S) | Common Stock | 14,609 | USD 29.91 | USD 436,935 | SEC 申报 ↗ |
| 2026-07-01 | Bernstein Harold | 期权行权／转换 (M) | Common Stock | 14,609 | USD 10.42 | USD 152,226 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | MAZE |
| CIK | 0001842295 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 151 transaction lines from 2025-02-03 to 2026-10-01 0 P purchase lines · 94 S sale lines · 57 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.